AT-008 (Affitech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAT-008 (Affitech)
Drug Alias Nameanti-CCR4 human monoclonal antibody (IBC Generium/Affitech)GNR-015
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionC-C chemokine receptor type 4 modulators
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffitech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNauchTechStroy Plus LLCInternational Biotechnology Center Generium LlcAffitech
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A